US Patent 7342100 Hpr6 mutants and uses thereof
Patent 7342100 was granted and assigned to University of Kentucky on March, 2008 by the United States Patent and Trademark Office.
All edits
Edits on 16 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Inventor Names
Rolf Joseph Craven0
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+246 characters)
Article
Patent abstract
Methods and agents that interfere with Hpr6 function in non-sarcoma tumor cells are disclosed. Anti-Hpr6 agents are used to enhance the killing effect of anti-cancer agents in non-sarcoma tumor cells and to teat non-sarcoma tumors.
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07342100 Hpr6 mutants and uses thereof US Patent 7342100 Hpr6 mutants and uses thereof
Infobox
Patent Number
073421000
Patent Number
73421000
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
073421000
Date of Patent
March 11, 2008
0Patent Application Number
108606490
Date Filed
June 4, 2004
0Official Website
Patent Primary Examiner
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 23 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07342100 Hpr6 mutants and uses thereof
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07342100
Date of patent
March 11, 2008
Patent application number
10860649
Date Filed
June 4, 2004
Patent primary examiner
Find more entities like US Patent 7342100 Hpr6 mutants and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.